FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

NK Altorki

Research Profile

Disorders

Physiology

Procedures

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Genes & Molecular Sequences

Genes, p53

Co-author Network

Publications

TOP 3
Robert A Soslow; C G Petersen; H Remotti; NK Altorki
Acidic fibroblast growth factor is expressed sequentially in the progression from Barrett's esophagus to esophageal adenocarcinoma.
Robert A Soslow; Y Nabeya; L Ying; M Blundell; NK Altorki
Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinoma.
Robert A Soslow; NK Altorki; G Yang; D Xie; C S Yang
mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of NK Altorki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Robert A Soslow; C G Petersen; H Remotti; NK Altorki
Acidic fibroblast growth factor is expressed sequentially in the progression from Barrett's esophagus to esophageal adenocarcinoma.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2001;14(1):23-7.
1999: Robert A Soslow; Y Nabeya; L Ying; M Blundell; NK Altorki
Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinoma.
Histopathology 1999;35(1):31-7.
1999: Robert A Soslow; NK Altorki; G Yang; D Xie; C S Yang
mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(6):580-6.
1999: Robert A Soslow; H Remotti; Rebecca N Baergen; NK Altorki
Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(3):239-50.
1995: Y Nabeya; F Loganzo; Peter Maslak; L Lai; A R de Oliveira; Gary K Schwartz; M L Blundell; NK Altorki; David P Kelsen; A P Albino
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
International journal of cancer. Journal international du cancer 1995;64(1):37-46.
1995: Anthony P Albino; J Jaehne; NK Altorki; M Blundell; C Urmacher; G Lauwers; D Niedzwiecki; David P Kelsen
Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(1):56-60.
1994: Gary K Schwartz; H Wang; N Lampen; NK Altorki; David P Kelsen; Anthony P Albino
Defining the invasive phenotype of proximal gastric cancer cells.
Cancer 1994;73(1):22-7.
1993: NK Altorki; Gary K Schwartz; M Blundell; B M Davis; David P Kelsen; Anthony P Albino
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Cancer 1993;72(3):649-57.
1990: E Rodriguez; Pulivarthi H Rao; Marc Ladanyi; NK Altorki; Anthony P Albino; David P Kelsen; Suresh C Jhanwar; Raju S K Chaganti
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.
Cancer research 1990;50(19):6410-6.
1990: David M Nanus; David P Kelsen; I R Mentle; NK Altorki; Anthony P Albino
Infrequent point mutations of ras oncogenes in gastric cancers.
Gastroenterology 1990;98(4):955-60.